Oak Associates’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-39,570
| Closed | -$1.92M | – | 140 |
|
|
2020
Q4 | $1.92M | Sell |
39,570
-3,810
| -9% | -$188K | 0.12% | 82 |
|
|
2020
Q3 | $2.18M | Hold |
43,380
| – | – | 0.15% | 68 |
|
|
2020
Q2 | $2.21M | Sell |
43,380
-20,040
| -32% | -$974K | 0.15% | 68 |
|
|
2020
Q1 | $2.77M | Hold |
63,420
| – | – | 0.23% | 60 |
|
|
2019
Q4 | $3.18M | Sell |
63,420
-15
| -0% | -$703 | 0.19% | 70 |
|
|
2019
Q3 | $2.94M | Sell |
63,435
-120
| -0.2% | -$5.17K | 0.18% | 73 |
|
|
2019
Q2 | $2.75M | Buy |
63,555
+17,635
| +38% | +$750K | 0.17% | 74 |
|
|
2019
Q1 | $2.03M | Sell |
45,920
-240
| -0.5% | -$10.3K | 0.12% | 82 |
|
|
2018
Q4 | $2M | Sell |
46,160
-72,760
| -61% | -$3.21M | 0.14% | 83 |
|
|
2018
Q3 | $5.31M | Buy |
118,920
+4,080
| +4% | +$174K | 0.32% | 66 |
|
|
2018
Q2 | $4.59M | Buy |
114,840
+250
| +0.2% | +$9.84K | 0.31% | 68 |
|
|
2018
Q1 | $4.59M | Buy |
114,590
+26,105
| +30% | +$1.09M | 0.32% | 68 |
|
|
2017
Q4 | $3.81M | Buy |
88,485
+21,285
| +32% | +$981K | 0.27% | 70 |
|
|
2017
Q3 | $3.35M | Hold |
67,200
| – | – | 0.25% | 78 |
|
|
2017
Q2 | $3.22M | Buy |
67,200
+2,000
| +3% | +$95.6K | 0.24% | 83 |
|
|
2017
Q1 | $2.95M | Hold |
65,200
| – | – | 0.24% | 86 |
|
|
2016
Q4 | $2.64M | Hold |
65,200
| – | – | 0.26% | 85 |
|
|
2016
Q3 | $2.54M | Buy |
65,200
+3,400
| +6% | +$136K | 0.26% | 84 |
|
|
2016
Q2 | $2.59M | Hold |
61,800
| – | – | 0.31% | 77 |
|
|
2016
Q1 | $2.48M | Buy |
61,800
+1,700
| +3% | +$68.3K | 0.3% | 76 |
|
|
2015
Q4 | $2.56M | Hold |
60,100
| – | – | 0.31% | 78 |
|
|
2015
Q3 | $2.85M | Buy |
60,100
+12,600
| +27% | +$642K | 0.38% | 59 |
|
|
2015
Q2 | $2.35M | Buy |
47,500
+14,300
| +43% | +$725K | 0.29% | 80 |
|
|
2015
Q1 | $1.64M | Hold |
33,200
| – | – | 0.2% | 96 |
|
|
2014
Q4 | $1.51M | Hold |
33,200
| – | – | 0.18% | 101 |
|
|
2014
Q3 | $1.87M | Hold |
33,200
| – | – | 0.23% | 89 |
|
|
2014
Q2 | $1.76M | Hold |
33,200
| – | – | 0.22% | 93 |
|
|
2014
Q1 | $1.74M | Sell |
33,200
-500
| -1% | -$25.3K | 0.21% | 93 |
|
|
2013
Q4 | $1.81M | Buy |
+33,700
| New | +$1.74M | 0.2% | 91 |
|
|
2013
Q2 | $1.74M | Buy |
+33,700
| New | +$1.8M | 0.21% | 83 |
|
Other funds holding SNY
Oak Associates's SNY Position: Q1 2021 in Review
Oak Associates sold out of Sanofi (SNY) in Q1 2021, closing a stake of 39,570 shares — an estimated $1.92M sold.
Oak Associates first reported a position in SNY in Q2 2013 and held it in 30 quarters. The position peaked at $5.31M in Q3 2018. 572 funds tracked by Wall St. Rank hold SNY as of Q1 2021.
- Oak Associates reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
- Oak Associates sold 39,570 Sanofi shares in Q1 2021, an estimated $1.92M.
- Oak Associates first reported a position in Sanofi in Q2 2013 and held it in 30 quarters.
- Oak Associates's Sanofi position peaked at $5.31M in Q3 2018.
- 572 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.
Based on Oak Associates's 13F filing for Q1 2021, filed 13 May 2021.